Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Proline links gut microbiome to depression

May 9, 2022

Orion enters agreement with Jemincare for Nav1.8 blocker for treatment of pain

May 6, 2022

Researchers discover HDAC1 as the cause of immune abnormalities in autistic mouse models

May 5, 2022

DGKk gene therapy rescues brain lipid profiles and long-term behavior in fragile X syndrome mice

May 5, 2022

Shujing Biopharma, Jiangsu Nhwa Pharmaceutical patent 5-HT2A/DRD2 antagonists

May 5, 2022

MJFF grant supports Asceneuron's preclinical evaluation of ASN-51 for Parkinson's disease

May 4, 2022

PRISM BioLab discovers Notch signaling inhibitors

May 4, 2022

Lilly patents dopamine D1 receptor positive allosteric modulators

May 3, 2022

Curome Biosciences presents new quinone derivatives

May 2, 2022

ProMIS reports potential therapeutic approaches for ALS and nominates lead candidate

April 29, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...